YOUR SEARCH FOR Text 194 RESULTS
101 of Total
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs …
102 of Total
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs …
103 of Total
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs …
104 of Total
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs …
105 of Total
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs …
106 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs …
107 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
… … Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs …
108 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
… … Incyte Announces Positive CHMP Opinion for Zynyz® …
109 of Total
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatm
… … Incyte Announces the European Commission Approval of Zynyz® …
110 of Total
Privacy Policy | Incyte.com
… Privacy Policy Last Updated: January 7, 2026 Incyte Corporation (including its affiliates in its worldwide …